Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Heron Therapeutics (HRTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 883,365
  • Shares Outstanding, K 53,700
  • Annual Sales, $ 1,280 K
  • Annual Income, $ -173,140 K
  • 36-Month Beta 2.05
  • Price/Sales 734.71
  • Price/Cash Flow 0.00
  • Price/Book 9.20

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.70 +34.45%
on 07/10/17
17.98 -5.03%
on 07/20/17
+2.03 (+13.46%)
since 06/23/17
3-Month
12.70 +34.45%
on 07/10/17
17.98 -5.03%
on 07/20/17
+1.83 (+11.97%)
since 04/25/17
52-Week
12.21 +39.84%
on 01/12/17
24.00 -28.85%
on 08/10/16
+0.56 (+3.36%)
since 07/25/16

Most Recent Stories

More News
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (HRTX, FGEN, NVTA, TGTX, ADRO)

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

TGTX : 11.62 (-3.57%)
NVTA : 9.35 (-0.43%)
FGEN : 35.25 (-0.84%)
ADRO : 13.80 (-1.08%)
HRTX : 17.05 (+0.89%)
SmarTrend Watching for Potential Pullback in Shares of Heron Therapeuti After 5.93% Gain

Heron Therapeuti (NASDAQ:HRTX) traded in a range yesterday that spanned from a low of $15.35 to a high of $16.60. Yesterday, the shares gained 5.9%, which took the trading range above the 3-day high...

HRTX : 17.05 (+0.89%)
Relatively Good Performance Detected in Shares of Cara Therapeutic in the Biotechnology Industry (CARA, MDXG, SGMO, DVAX, HRTX)

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

SGMO : 9.35 (-1.06%)
CARA : 15.23 (+0.33%)
MDXG : 14.90 (-0.73%)
DVAX : 10.00 (-6.10%)
HRTX : 17.05 (+0.89%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (ALDR, HRTX, ADXS, BLCM, CARA)

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

ADXS : 6.78 (-0.15%)
CARA : 15.23 (+0.33%)
ALDR : 11.40 (-4.20%)
BLCM : 12.14 (+1.08%)
HRTX : 17.05 (+0.89%)
Amicus Therapeut has the Best Relative Performance in the Biotechnology Industry (FOLD, ENTA, HRTX, SGMO, RDUS)

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

FOLD : 13.66 (-0.65%)
SGMO : 9.35 (-1.06%)
ENTA : 37.66 (-0.32%)
RDUS : 42.82 (-0.97%)
HRTX : 17.05 (+0.89%)
Research Reports Initiation on Drug Makers Stocks -- Immune Pharma, Impax Labs, Heron Therapeutics, and Alimera Sciences

For today, Stock-Callers.com presents for evaluation four major players in the Drug Manufacturers space, which are: Immune Pharmaceuticals Inc. (NASDAQ: IMNP), Impax Laboratories Inc. (NASDAQ: IPXL), Heron...

ALIM : 1.46 (unch)
IMNP : 2.40 (-1.64%)
IPXL : 19.33 (+3.09%)
HRTX : 17.05 (+0.89%)
Heron Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress

Heron Therapeutics, Inc. (Nasdaq:HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel best-in-class treatments to address some of the biggest...

HRTX : 17.05 (+0.89%)
Blog Coverage Zogenix Announces Completion of Enrollment for the Phase III Trial in Dravet Syndrome

Upcoming AWS Coverage on Heron Therapeutics Post-Earnings Results

ZGNX : 13.05 (-2.61%)
HRTX : 17.05 (+0.89%)
Heron Therapeutics Appoints Robert E. Hoffman as Chief Financial Officer and Senior Vice President, Finance

Heron Therapeutics, Inc. (NASDAQ:HRTX), a commercial-stage biotechnology company focused on developing novel best-in-class treatments to address some of the biggest unmet patient needs, announced...

HRTX : 17.05 (+0.89%)
Overcoming Opioids: The quest for less addictive drugs

Tummy tucks really hurt. Doctors carve from hip to hip, slicing off skin, tightening muscles, tugging at innards. Patients often need strong painkillers for days or even weeks, but Mary Hernandez went...

PFE : 33.14 (-0.54%)
HRTX : 17.05 (+0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators mostly agree with the trend.

See More

Business Summary

Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting....

See More

Support & Resistance

2nd Resistance Point 17.47
1st Resistance Point 17.18
Last Price 17.05
1st Support Level 16.38
2nd Support Level 15.87

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.